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INTRODUCTION
Fever of unknown origin (FUO), defined as a temperature
higher than 38.3˚C on several occasions and lasting longer
than three weeks that is associated with a diagnosis that
remains uncertain after one week of investigation (1), is a
frequent condition in the infectious diseases specialty clinic.
The condition is often associated with extensive diagnostic
procedures and, not rarely, frustration for both the patient
and the physician. An evidence-based approach has been
used to group the causes of FUO (2) into four general
categories: infectious, rheumatic/inflammatory, neoplastic,
and miscellaneous disorders (3). Infectious diseases such as
endocarditis, intra-abdominal abscesses, and tuberculosis, as
well as inflammatory conditions such as temporal arteritis,
adult’s Still disease, and late-onset rheumatoid arthritis, are
commonly identified causes of FUO (3). However, unex-
pected and rare causes are sometimes diagnosed, as reported
below in a case of sclerosing mesenteritis.
CASE DESCRIPTION
A 44-year-old, previously healthy man was referred to the
infectious disease specialist for the investigation of fever that
had occurred in the previous 10 days and fatigue that had
been present for the previous 30 days. He reported being
chronically constipated, which had worsened over the
previous 30 days. The daily fever was the main complaint
and arose at any time of the day without chills or notable
sweats; no weight loss was reported. The physical examina-
tion was unremarkable, and the initial laboratory findings
revealed only a low positive protein levels as determined by
urinalysis and slight increases in the levels of C-reactive
protein and the erythrocyte sedimentation rate, with a
normal complete blood count. Tests for mononucleosis-like
agents were negative for active infections. The patient was
hospitalized for additional exams and evaluation. Fever (38-
38.5˚C) was confirmed, but it disappeared right after the
introduction of a nonsteroidal anti-inflammatory medication
(naproxen). Echocardiography, blood cultures, an eye fundo-
scopic examination, and a colonoscopy were all unremark-
able.Thepatient wasthen submittedtoabdominaland pelvic
computed tomography (CT) scans, which revealed a mural
thickness in the sigmoid colon with nodular densities in
adjacent adipose tissue (Figure 1A). Large numbers of
lymph nodes up to 1.0 cm in diameter were observed near
the inferior mesenteric vessels. An intestinal lymphoma
was initially suspected, and the patient was submitted to
abdominal laparoscopic surgery with rectosigmoidectomy
and lymph node resection. The intraoperative aspect was
of a chronic inflammatory lesion affecting the entire mural
thickness and adjacent tissues in addition to moderate
dilation of the proximal colon (Figure 1B). After hematox-
ylin-eosin staining, the histopathologic exam revealed
extensive lymphoplasmocytic inflammatory infiltrate with
collagenic deposition involving the mesenteric adipocytes
(Figures 1C and 1D). Staining for IgG4 was negative in the
inflamed tissue.
After the surgical procedure, clinical recovery was
adequate, and there was no rebound of fever or weakness
after discontinuation of the nonsteroidal anti-inflammatory
drug. At a follow-up visit eight months later, the patient
remained asymptomatic and no longer complained of
intestinal bowel symptoms or fever.
DISCUSSION
Sclerosing mesenteritis is a rare idiopathic condition
characterized by a non-neoplastic inflammatory process in
the mesenteric fat (4). Men are more commonly affected
than women, and the incidence increases in middle-aged
and older adults (5). The clinical presentation and radi-
ological findings are nonspecific, which renders the condi-
tion a diagnostic challenge for surgeons and internists.
Granulomatous and neoplastic diseases are part of the
differential diagnosis for sclerosing mesenteritis on clinical
and radiological grounds (6). Therefore, histopathology
remains the main diagnostic tool (7). The histological
findings are fibrosis, myofibroblasts, and inflammatory cell
infiltration of the fatty tissue with degeneration or fat
necrosis; aggregations of lipid-laden foamy macrophages
are also present (4,8). The process can be predominantly
inflammatory with fat tissue inflammation and necrosis
(mesenteric panniculitis) or predominantly fibrotic, which
leads to retractile mesenteritis (7-9).
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with a multisystem clinical syndrome affecting the pancreas,
biliary tract, liver, kidneys, and lungs; this condition has been
described as ‘‘IgG4-related systemic sclerosing disease’’, and
one of the most common histopathological features is the
presence of IgG4+ plasma cells within involved tissues (10).
However, cases of sclerosing mesenteritis have also been
described in the absence of other sites of involvement.
The likely causal relationship of the disease and FUO in this
case is supported by the lack of any other diagnosis, the
confirmatory histological findings of sclerosing mesenteritis,
and the remission of fever with nonsteroidal anti-inflammatory
drug use and the surgical removal of involved tissue. At a
follow-up visit,thepatient remained asymptomatic, suggesting
that the local process was the only cause of FUO. Case reports
of sclerosing mesenteritis as a cause of FUO are rare, and we
were able to identify only seven cases after a thorough review
of the medical literature (Table 1).
The best treatment for sclerosing mesenteritis remains
unclear. Asymptomatic or mild clinical forms may some-
times be left untreated with spontaneous recovery (8).
Surgical resection is required for patients with intestinal
obstruction and perforation, and immunosuppressive ther-
apy with corticosteroids, thalidomide, and other drugs has
been recommended by some authors (7,8). In the present
case, surgical removal was able to limit the process. The
prognosis is mainly dependent on a correct diagnosis and
on the extension of the fibrotic process (9).
Fever has not often been described as a symptom of
sclerosing mesenteritis. In this case report, a long-lasting
fever was the clinical hallmark of FUO. Although rare,
physicians should be aware of this possibility.
Figure 1 - A: Abdominal and pelvic CT scan showing mural thickening of the sigmoid colon with densification of the adjacent
mesenteric fat (white arrow) and an increased number of lymph nodes up to 1.0 cm in diameter near the inferior mesenteric vessels; B:
Surgical photography showing the inflamed sigmoid; C and D: microscopic exam after hematoxylin-eosin staining showing an
extensive lymphoplasmocytic inflammatory infiltrate with collagenic deposition involving the mesenteric adipocytes at 100x (C) and
400x (D) magnifications.
Table 1 - Case reports of sclerosing mesenteritis as a cause of FUO.
Author, year
Age (years),
gender
Days with
fever Associated symptoms Diagnostic criteria Tissue IgG4 Outcome
Otto et al., 1991
11 76, M 14 Abdominal pain, weight
loss, shivering
CT and laparoscopic
biopsy
Not available Fever resolved under
corticosteroid therapy, and the
patient remained well three
months after the onset of
treatment
Sans et al., 1995
12 40, M 30 Shivering and myalgia USG, CT, NMR and
laparoscopic biopsy
Not available Intermittent episodes of fever
and muscle pain 2 years and 5
months after prednisone and
azathioprine therapy
Hemaidan et al.,
1999
13
61, M 60 Headache, myalgia,
mental status changes,
Sjo ¨grens syndrome
CT, autopsy Not available Symptoms maintained until
death by sudden cardiac arrest
Papadaki et al.,
2000
14
66, M 90 Anorexia, weight loss,
autoimmune hemolytic
anemia, chylous ascites
CT and laparotomy
biopsy
Not available Improvement in anemia and
fever relief following
prednisone and azathioprine
with no change in the
mesenteric lesions
Martı ´nez Odriozola
et al., 2003
15
59, F 21 None CT and laparoscopic
biopsy
Not available Symptoms resolved after
treatment with prednisone 1
mg/kg/d for 6 months
Ruiz Garcı ´a et al.,
2007
16
55, M .15 Malaise and sweating CT and open-surgery
biopsy
Not available Symptoms resolved after
treatment with oral
corticosteroids for 2 years
Ferrari et al, 2008
17 36, M 42 Chills, weight loss Open-surgery biopsy Not available Symptoms resolved after
treatment with oral
corticosteroids for 5 months
Avelino-Silva et al.,
2011
44, M 10 Fatigue and worsened
constipation
CT and laparoscopic
resection
Normal Symptoms resolved after
surgical treatment
M=male; F=female; CT= computed tomography; USG=ultrasonography; NMR=nuclear magnetic resonance.
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